Brief: Brickell Biotech Announces Publication Of HDSM-AX Patient Reported Outcome Scale Validation Results In The Journal Of Drugs In Dermatology
15/04/2021 13:36
April 15 (Reuters) - Brickell Biotech Inc BBI.O :
* BRICKELL BIOTECH ANNOUNCES PUBLICATION OF ITS HDSM-AX
PATIENT
REPORTED OUTCOME SCALE VALIDATION RESULTS IN THE JOURNAL OF
DRUGS IN DERMATOLOGY
Source text for Eikon: ID:nGNXcdpdjk
Further company coverage: BBI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Fresh Tracks Therapeutics
See all newsBrief: Fresh Tracks Therapeutics Announces Second Adjournment Of Special Meeting Of Stockholders
Brief: Fresh Tracks Therapeutics Intends To Seek Judicial Dissolution If Liquidation And Approved By Stockholders
Brief: Fresh Tracks Therapeutics Q3 EPS USD 0.32
Brief: Fresh Tracks Therapeutics Inc On October 10 Received A Notice From Listing Qualifications Department Of Nasdaq
U.S. STOCKS ON THE MOVE-Gold miners, Goosehead Insurance, FedEx